Trine Pilgaard, Director, Market Access at Pfizer Aps. is a Global Market Access Leader with more than 15 years of experience working in the pharmaceutical industry. Trine started her career at the World Health Organization, working in the pharmaceutical department, where she co-led and co-authored the EU-funded Pharmaceutical Pricing & Information Project (PPRI). She then moved to Novo Nordisk, where she had various roles within Global Market Access, amongst others, working to support the launch of new assets within hemophilia. After Novo Nordisk, Trine joined the Global Leadership team at Lundbeck, responsible for launching their new schizophrenia product. Today, Trine heads-up Pfizer Aps’s Market Access department, ensuring access and reimbursement of Pfizer’s products in Denmark & Iceland. Trine’s department is responsible for Health Technology Assessments, Health Economics, Market Access, Outcomes Research, Real-World Evidence, pricing, and tenders. In addition to her role as Director, Market Access at Pfizer, Trine is active in the Danish Trade Association and part of the committee of Hospital Medicines. Trine holds a Master in Public Health Science from the University of Copenhagen and furthermore a Master in Health Services Management from the University of London School of Hygiene and Tropical Medicines / London School of Economics. Trine is especially interested in the generation of Real-World Evidence and has, throughout her career, published +10 peer-reviewed full-scale publications.